153186-10-8

Basic information

• Product Name: 1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-L-Lyxofuranose
• Synonyms: 1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-L-Lyxofuranose;1,2-O-(1-Methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-beta-L-lyxofuranose;(3aR,5R,6S,6aR)-6-(benzyloxy)-5-(benzyloxymethyl)-2,2-dimethyl-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl] methanol;1,2-Di-O-isopropylidene-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)--L-lyxofuranose;3-O-Benzyl-1,2-O-isoproylidene-4-C-(phenylmethoxy)methyl-β-L-lyxofuranose;β-L-Lyxofuranose, 1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl);3-O-Benzyl-1,2-O-isoproylidene-4-C-(phenylmethoxy)methyl-b-L-lyxofuranose
• CAS NO: 153186-10-8
• Molecular Formula: C₂₃H₂₈O₆
• Molecular Weight: 400.46482
• Mol File: 153186-10-8.mol
• Article Data: 19

Chemical Properties

• Boiling Point: 518.5±50.0 °C(Predicted)
• Appearance: /
• Density: 1.24±0.1 g/cm3(Predicted)
• PKA: 14.25±0.10(Predicted)
• CAS DataBase Reference: 1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-L-Lyxofuranose(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-L-Lyxofuranose(153186-10-8)
• EPA Substance Registry System: 1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-L-Lyxofuranose(153186-10-8)

Safety Data

• Hazardous Substances Data: 153186-10-8(Hazardous Substances Data)

Usage

Uses

3-O-Benzyl-1,2-O-isoproylidene-4-C-(phenylmethoxy)methyl-b-L-lyxofuranose is a useful research chemical.

Upstream product

• 100-39-0 benzyl bromide 
• 63593-03-3 1,2-O-isopropylidene-3-O-benzyl-4-hydroxymethyl-α-D-ribofuranose 
• 22393-62-0 BnBr 
• 63593-02-2 3-O-benzyl-1,2-O-isopropylidene-α-D-ribo-pentodialdo-1,4-furanose 
• 1013943-40-2 3-O-benzyl-1,2:5,6-di-O-isopropylidene-α-D-allofuranose 
• 620630-82-2 1,2 5,6-O-di(isopropylidene)-α-D-allofuranose 
• 57099-04-4 3-O-benzyl-1,2-O-isopropylidene-α-D-allofuranose 
• 22331-21-1 1,2:5,6-di-O-isopropylidene-3-O-benzyl-α-D-allofuranose 
• 2595-05-3 Diacetone D-glucose 
• 100-44-7 benzyl chloride 

Downstream Products

• 233266-76-7 (3aR,5R,6S,6aR)-6-(benzyloxy)-5-((benzyloxy)methyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole-5-carbaldehyde 
• 263547-07-5 3-O-benzyl-4-[(benzyloxy)methyl]-1,2-O-(1-methylethylidene)-5-O-(trifluoromethylsulfonyl)-β-L-lyxofuranose 
• 1610605-74-7 (2R,3R,4S,5R)-2-(2-amino-6-chloro-9H-purin-9-yl)-4-(benzyloxy)-5-((benzyloxy)methyl)-5-(2-(tosyloxy)ethyl)tetrahydrofuran-3-yl acetate 
• 1610605-75-8 2-amino-9-((1R,5R,7R,8S)-8-(benzyloxy)-5-((benzyloxy)methyl)-2,6-dioxabicyclo[3.2.1]octan-7-yl)-1H-purin-6(9H)-one 
• 287737-62-6 2-((3aR,5R,6S,6aR)-6-(benzyloxy)-5-((benzyloxy)methyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)ethanol 
• 287737-63-7 (3aR,5R,6S,6aR)-6-(benzyloxy)-5-((benzyloxy)methyl)-2,2-dimethyl-5-vinyltetrahydrofuro[2,3-d][1,3]dioxole 
• 945382-94-5 C₂₆H₃₀O₇ 
• 945382-92-3 4-C-allyl-3,5-di-O-benzyl-1,2-O-isopropylidene-α-D-ribofuranose 
• 287737-61-5 C₂₄H₂₈O₆ 
• 945383-20-0 (1R,2R,5R,7R,8S)-8-benzyloxy-5-benzyloxymethyl-2-methyl-7-(thymin-1-yl)-6-oxa-bicyclo[3.2.1]octane 
• 945383-18-6 1-[3,5-di-O-benzyl-4-C-penten-yl-2-O-phenoxythiocarbonyl-β-D-ribofuranosyl]-thymine 
• 945383-16-4 1-[3,5-di-O-benzyl-4-C-penten-yl-2-hydroxy-β-D-ribofuranosyl]-thymine 
• 945383-14-2 C₃₀H₃₄N₂O₇ 
• 945383-12-0 3,5-di-O-benzyl-4-C-penten-yl-1,2-O-isopropylidene-α-D-ribofuranose 

Relevant articles and documents

NUCLEOTIDE AND NUCLEOSIDE THERAPEUTICS COMPOSITIONS AND USES RELATED THERETO

This disclosure relates to nucleotide and nucleoside therapeutic compositions and uses in treating infectious diseases, viral infections, and cancer, where the base of the nucleotide or nucleoside contains at least one thiol, thione or thioether.

NUCLEOTIDE AND NUCLEOSIDE COMPOSITIONS AND USES RELATED THERETO

This disclosure relates to nucleotide and nucleoside therapeutic compositions and uses in treating infectious diseases, viral infections, and cancer, where the base of the nucleotide or nucleoside contains at least one thiol, thione or thioether.

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

Disclosed herein are nucleosides, nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a Filoviridae virus infection with one or more nucleosides and/or nucleotide analogs.